Clinical trial
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery
NCT04246554 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 21, 2019
- Completion date
- January 1, 2021
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acl injury, postoperative pain